CombiMatrix Corp. Company Profile (NASDAQ:CBMX)

Analyst Ratings

Consensus Ratings for CombiMatrix Corp. (NASDAQ:CBMX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for CombiMatrix Corp. (NASDAQ:CBMX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for CombiMatrix Corp. (NASDAQ:CBMX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
2/17/2016Q4 15($2.40)($2.02)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315($0.18)($0.13)$2.70 million$2.53 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215($0.16)($0.13)$2.40 million$2.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.16)($0.23)$2.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2015Q414($0.19)($0.15)$2.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314($0.25)($0.23)$1.50 million$2.06 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q2 2013($0.03)$1.31 million$1.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2013Q4 2012($3.31)$1.25 million$1.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312($0.12)$1.24 million$1.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for CombiMatrix Corp. (NASDAQ:CBMX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($1.39)($1.39)($1.39)
Q3 20161($1.21)($1.21)($1.21)
Q4 20161($1.15)($1.15)($1.15)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for CombiMatrix Corp. (NASDAQ:CBMX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for CombiMatrix Corp. (NASDAQ:CBMX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/10/2016Robert HoffmanDirectorBuy5,000$3.19$15,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016Scott GottliebDirectorBuy4,000$3.03$12,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2016Scott R. BurellCFOSell454$4.50$2,043.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2016Mark D. McdonoughCEOSell7,938$0.54$4,286.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2016Scott R. BurellCFOSell3,070$0.54$1,657.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2016Mark D. McdonoughCEOSell13,614$0.55$7,487.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2016Scott R. BurellCFOSell5,266$0.55$2,896.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Mark D McdonoughCEOBuy12,000$2.02$24,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Robert Weslie TysonInsiderBuy7,500$2.04$15,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Scott R BurellCFOBuy1,000$2.04$2,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014R Judd JessupDirectorSell13,679$2.00$27,358.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2013Mark D McdonoughCEOBuy1,500$2.85$4,275.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2013Richard Hockett JrInsiderBuy1,000$2.77$2,770.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for CombiMatrix Corp. (NASDAQ:CBMX)
DateHeadline
06/29/16 08:08 PMNewly released market study: CombiMatrix Corporation (CBMX) - Financial and Strategic SWOT Analysis Review
06/28/16 01:30 PMCBMX: Largest Study To-Date Further Supports Superiority of CMA -
06/24/16 11:11 AMCombiMatrix Study Published in Genetics in Medicine Establishes the Superior Diagnostic Value of Microarray Analysis over Karyotyping for Recurrent…
06/24/16 05:20 AMCombiMatrix Study Published in Genetics in Medicine Establishes the Superior Diagnostic Value of Microarray Analysis over Karyotyping for Recurrent Pregnancy Loss Testing - [at noodls] - Data further validates CombiMatrix's microarray testing for miscarriage analysis and supports position as commercial and scientific leader in the $300 million annual U.S. market IRVINE, Calif., June 24, ...
06/24/16 05:13 AM6:13 am CombiMatrix announces the publication of data from a large retrospective study 'demonstrating a high success rate and superior diagnostic power of chromosomal microarray analysis for recurrent pregnancy loss testing' -
06/21/16 03:11 PMCOMBIMATRIX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/01/16 05:13 AMCombiMatrix Launches Next Generation Sequencing for Pre-Implementation Genetic Screening - [at noodls] - High sensitivity and specificity PGS testing by Next Generation Sequencing supports healthy pregnancies and builds on prenatal diagnostics portfolio IRVINE, Calif., June 01, 2016 (GLOBE NEWSWIRE) -- CombiMatrix ...
05/25/16 05:26 AMCombiMatrix to Present at Upcoming Investment Conferences - [at noodls] - IRVINE, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre-implantation genetic diagnostics ...
05/19/16 12:04 PMCOMBIMATRIX CORP Financials -
05/13/16 11:02 AMCombiMatrix Corp. :CBMX-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/10/16 05:08 AMCombiMatrix Comments on Additional Medical Policy Revisions to Reimburse for Recurrent Pregnancy Loss Testing - [at noodls] - Genetic testing now categorized by six additional health plans as medically necessary for the evaluation of pregnancy loss in specific cases IRVINE, Calif., May 10, 2016 (GLOBE NEWSWIRE) -- CombiMatrix ...
05/06/16 02:25 PMCBMX: Reimbursement Very Strong, Could Be At Inflection Point -
05/04/16 03:10 PMCombiMatrix Corporation Reports First Quarter 2016 Financial and Operating Results - [at noodls] - Revenues Increase 28% to $3.0 Million on Record Reproductive Health Genetic Screening Test Volume and Higher Average Revenue per Test Conference Call Begins Today at 4:30 p.m. Eastern Time IRVINE, Calif., ...
04/27/16 03:19 PMCOMBIMATRIX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits -
04/27/16 05:18 AMCombiMatrix Corporation to Release 2016 First Quarter Financial Results on May 4, 2016 - [at noodls] - IRVINE, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three months ended March 31, 2016 after market close on ...
04/09/16 01:23 PMCombiMatrix Corporation (CBMX) Latest Broker Views - Risers & Fallers - CombiMatrix Corporation (CBMX) Latest Broker ViewsRisers & FallersA number of investment brokers have recently updated their price targets on shares of CombiMatrix Corporation (CBMX). According to the latest broker reports outstanding on Friday 8th of April, 1 analyst has a rating of “strong buy”, 1 analysts “buy”, 0 ...
04/05/16 05:56 AMCombiMatrix Launches Preimplantation Genetic Diagnostic Testing for Single Gene Disorders and Chromosomal Translocations - [at noodls] - IRVINE, Calif., April 05, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental ...
03/29/16 05:11 AMCombiMatrix Comments on Medical Policy Revisions by Cigna Health and Three BCBS Health Plans to Reimburse for Recurrent Pregnancy Loss Testing - [at noodls] - Six plans over the past 10 weeks announce coverage for chromosomal microarray testing for recurrent pregnancy loss IRVINE, Calif., March 29, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), ...
03/24/16 10:13 AMCOMBIMATRIX CORP Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to Articles of I -
03/23/16 05:00 AMACOG and SMFM Update Practice Bulletins Recommending Prenatal Genetic Assessment for All Pregnant Women Regardless of Age or Other Risk Factors - [GlobeNewswire] - IRVINE, Calif., March 23, 2016-- CombiMatrix Corporation, a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental disorders and pre-implantation ...
03/19/16 01:49 PMRecent Broker Updates On CombiMatrix Corporation (CBMX) - Risers & Fallers - Recent Broker Updates On CombiMatrix Corporation (CBMX)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of CombiMatrix Corporation (CBMX). The latest broker reports which are currently outstanding on Thursday 17th of March state 1 analyst has a rating of “strong buy”, 1 ...
03/19/16 01:49 PMCombimatrix Corporation (NASDAQ:CBMX) Shorted Shares Decreased By 7.14% - Clinton Financial - Combimatrix Corporation (NASDAQ:CBMX) Shorted Shares Decreased By 7.14%Clinton FinancialThe stock of Combimatrix Corporation (NASDAQ:CBMX) registered a decrease of 7.14% in short interest. CBMX's total short interest was 18,200 shares in March as published by FINRA. Its down 7.14% from 19,600 shares, reported previously. With 14,200 ...Could CombiMatrix Corp See a Reversal After This Very Strong Session?Business Standard Tribuneall 2 news articles »
03/09/16 05:00 AMCombiMatrix to Present at the ROTH Conference - [GlobeNewswire] - IRVINE, Calif., March 09, 2016-- CombiMatrix Corporation, a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental disorders and pre-implantation ...
03/04/16 06:28 AM8 Stocks Under $10 to Trade for Big Gains -
02/28/16 01:16 PMCombimatrix Corporation (NASDAQ:CBMX) Shorted Shares Increased By 192.54% - Clinton Financial - Combimatrix Corporation (NASDAQ:CBMX) Shorted Shares Increased By 192.54%Clinton FinancialThe stock of Combimatrix Corporation (NASDAQ:CBMX) registered an increase of 192.54% in short interest. CBMX's total short interest was 19,600 shares in February as published by FINRA. Its up 192.54% from 6,700 shares, reported previously.
02/26/16 08:27 AMLatest Analysts Reports On CombiMatrix Corporation (CBMX) - Risers & Fallers - Latest Analysts Reports On CombiMatrix Corporation (CBMX)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of CombiMatrix Corporation (CBMX). The latest broker reports which have been released state 1 analyst has a rating of “buy”, 1 analysts “outperform”, 0 analysts “hold”, 0 ...
02/26/16 05:00 AMCombiMatrix Forms Scientific Advisory Board; Includes Leaders in Reproductive Health, Pathology, Genetics, Molecular Biology and Health Policy - [GlobeNewswire] - IRVINE, Calif., Feb. 26, 2016-- CombiMatrix Corporation, a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental disorders and pre-implantation ...
02/24/16 01:58 PMCombimatrix Corp (CBMX) Files Form 4 Insider Selling : Scott R Burell Sells 454 Shares - Los Angeles Mirror - Combimatrix Corp (CBMX) Files Form 4 Insider Selling : Scott R Burell Sells 454 SharesLos Angeles MirrorCombimatrix Corp (CBMX): Scott R Burell , CFO, Secretary & Treasurer of Combimatrix Corp sold 454 shares on Feb 23, 2016. The Insider selling transaction was disclosed on Feb 24, 2016 to the Securities and Exchange Commission in a Form-4 filing.The CFO - Secretary & Treasurer of CombiMatrix Corp (NASDAQ:CBMX), Scott Burell Sold 454 SharesFranklin IndependentStocks Swings: CombiMatrix Corporation (NASDAQ:CBMX), Halliburton Company (NYSE:HAL), Yahoo! Inc.Stock TranscriptStocks in Stealth Mode: PC Connection, Inc., CombiMatrix Corporation (NASDAQ:CBMX), Zafgen (NASDAQ:ZFGN)Property Mentorall 5 news articles »
02/24/16 01:58 PMStocks in Stealth Mode: PC Connection, Inc., CombiMatrix Corporation (NASDAQ:CBMX), Zafgen (NASDAQ:ZFGN) - On 18 February, Zafgen (NASDAQ:ZFGN), announced positive efficacy results from its Phase 2b ZAF-203 clinical trial evaluating beloranib, a MetAP2 inhibitor, in the treatment of severe obesity complicated by type 2 diabetes. The clinical trial achieved its ...
02/22/16 12:07 PMEdited Transcript of CBMX earnings conference call or presentation 17-Feb-16 9:30pm GMT -
02/22/16 10:28 AMCombiMatrix Corp. Earnings Analysis: 2015 By the Numbers -
02/20/16 01:03 PMCould CombiMatrix Corp Gain Strenght? The Stock Reaches All-Time Low - Franklin Independent - Could CombiMatrix Corp Gain Strenght? The Stock Reaches All-Time LowFranklin IndependentThe stock of CombiMatrix Corp (NASDAQ:CBMX) reached all time low today, Feb, 19 and still has $4.63 target or 11.00% below today's $5.20 share price. This indicates more downside for the $4.13M company. This technical setup was reported by ...and more »
02/19/16 01:19 PMCombiMatrix Corporation (CBMX) Analyst Updates - Risers & Fallers - CombiMatrix Corporation (CBMX) Analyst UpdatesRisers & FallersA number of investment brokers have recently updated their price targets on shares of CombiMatrix Corporation (CBMX). According to the latest broker reports outstanding on Friday 19th of February, 1 analyst has a rating of “strong buy”, 1 analysts “buy ...
02/19/16 09:35 AMCBMX: Solid Q4, PGS and Miscarriage On A Tear -
02/18/16 03:19 PMCOMBIMATRIX CORP Files SEC form 10-K, Annual Report -
02/18/16 12:58 PMCombiMatrix Regains Compliance With NASDAQ Listing Requirements (NASDAQ:CBMX) - WallStreet.org - CombiMatrix Regains Compliance With NASDAQ Listing Requirements (NASDAQ:CBMX)WallStreet.orgThe compliance matter has been closed. Shares of CBMX are at $5.36 within a 52-week range of $5.06 – $32.40. The stock increased 4.48% or $0.23 on February 16, hitting $5.36. CombiMatrix Corp (NASDAQ:CBMX) has declined 77.94% since July 13, ...
02/18/16 12:58 PMEARNINGS SUMMARY: Details of CombiMatrix Corporation Q4 Earnings Report - Below are the earnings highlights for CombiMatrix Corporation (CBMX): -Earnings: -$1.54 million in Q4 vs. -$1.62 million in the same period last year. -EPS: -$2.02 in Q4 vs. -$2.19 in the same period last year. -Revenue: $2.68 million in Q4 vs. $2.22 ...
02/17/16 03:05 PMCombiMatrix Corporation Reports 2015 Fourth Quarter and Full Year Financial and Operating Results - [GlobeNewswire] - Revenue Growth of 21% for the Quarter Driven by Record Miscarriage Analysis and Pre-Implantation Genetic Screening Test Volumes Conference Call Begins Today at 4:30 p.m. Eastern Time. IRVINE, Calif., Feb. ...
02/17/16 06:07 AMQ4 2015 CombiMatrix Corp Earnings Release - After Market Close -
02/17/16 05:10 AMCOMBIMATRIX CORP Files SEC form 8-K, Other Events -
02/17/16 05:00 AMCombiMatrix Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement - [GlobeNewswire] - IRVINE, Calif., Feb. 17, 2016-- CombiMatrix Corporation, a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage analysis and postnatal developmental disorders ...
02/15/16 01:15 PM13G Filing: Acuta Capital Partners Files on Combimatrix Corp (CBMX) -
02/13/16 12:16 PMCombimatrix Corporation (NASDAQ:CBMX) Sellers Covered 15.96% of Their Shorts - fdanewsalert.com - Combimatrix Corporation (NASDAQ:CBMX) Sellers Covered 15.96% of Their Shortsfdanewsalert.comThe stock of Combimatrix Corporation (NASDAQ:CBMX) registered a decrease of 15.96% in short interest. CBMX's total short interest was 101,100 shares in February as published by FINRA. Its down 15.96% from 120,300 shares, reported previously.
02/11/16 12:18 PMCombiMatrix Comments on Revised Reimbursement Policies for Recurrent Pregnancy Loss - CNNMoney - CombiMatrix Comments on Revised Reimbursement Policies for Recurrent Pregnancy LossCNNMoney11, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental disorders and pre-implantation genetic screening services, ...and more »
02/11/16 05:00 AMCombiMatrix Comments on Revised Reimbursement Policies for Recurrent Pregnancy Loss - [GlobeNewswire] - IRVINE, Calif., Feb. 11, 2016-- CombiMatrix Corporation, a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental disorders and pre-implantation ...
02/09/16 11:52 AMCombiMatrix Migrates Miscarriage Analysis Microarray Testing to Newer Scanning Panel - Nasdaq - CombiMatrix Migrates Miscarriage Analysis Microarray Testing to Newer Scanning PanelNasdaqIRVINE, Calif., Feb. 09, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental disorders and pre-implantation genetic ...and more »
02/09/16 11:52 AMCombiMatrix Corp Stock Set to Reverse Split on Monday, February 1st (CBMX) - CombiMatrix Corp (NASDAQ:CBMX) shares are scheduled to reverse split on Monday, February 1st, MarketBeat reports. The 1-15 reverse split was announced on Wednesday, January 27th. The number of shares owned by shareholders will be adjusted after the market ...
02/09/16 05:00 AMCombiMatrix Migrates Miscarriage Analysis Microarray Testing to Newer Scanning Panel - [GlobeNewswire] - IRVINE, Calif., Feb. 09, 2016-- CombiMatrix Corporation, a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental disorders and pre-implantation ...
02/08/16 11:52 AMCombimatrix Corporation (NASDAQ:CBMX) Short Interest Decreased By 11.41% - fdanewsalert.com - Combimatrix Corporation (NASDAQ:CBMX) Short Interest Decreased By 11.41%fdanewsalert.comThe stock of Combimatrix Corporation (NASDAQ:CBMX) registered a decrease of 11.41% in short interest. CBMX's total short interest was 120,300 shares in February as published by FINRA. Its down 11.41% from 135,800 shares, reported previously.CombiMatrix Corporation to Release 2015 Fourth Quarter and Full Year Financial Results on February 17, 2016EIN News (press release)all 2 news articles »
02/08/16 05:00 AMCombiMatrix Corporation to Release 2015 Fourth Quarter and Full Year Financial Results on February 17, 2016 - [GlobeNewswire] - IRVINE, Calif., Feb. 08, 2016-- CombiMatrix Corporation announces that it will release financial results for the three months and full year ended December 31, 2015 after market close on Wednesday, February ...

Social

About CombiMatrix Corp.

CombiMatrix Corporation is a provider of molecular diagnostic solutions. The Company specializes in pre-implantation genetic screening, miscarriage analysis, prenatal diagnosis and pediatric developmental disorders, offering deoxyribonucleic acid-based testing for the detection of genetic abnormalities, which cannot be identified through traditional methodologies. It performs genetic testing utilizing a range of cytogenomic techniques, including chromosomal microarray analysis, fluorescence in situ hybridization and karyotyping. Its prenatal and postnatal microarray focuses on diagnosing genomic syndromes associated with intellectual disability, developmental delays, congenital anomalies, dysmorphic features and autism spectrum disorders. It develops and markets its molecular testing services in approximately four markets, such as in vitro fertilization (IVF), miscarriage analysis (products of conception analysis), prenatal genetics and postnatal developmental disorders.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CBMX
  • CUSIP:
Key Metrics:
  • Previous Close: $3.51
  • 50 Day Moving Average: $3.12
  • 200 Day Moving Average: $4.37
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $5.01M
  • Beta: 0.35
  • Current Year EPS Consensus Estimate: $-1.31 EPS
  • Next Year EPS Consensus Estimate: $-8.10 EPS
Additional Links:
CombiMatrix Corp. (NASDAQ:CBMX) Chart for Monday, July, 25, 2016